FDA granted tentative approval for Olaparib tablets, manufactured by Natco Pharma, which are bioequivalent to Lynparza.
1 report, 1 independent
Updated Jul 20
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
FDA granted tentative approval for Olaparib tablets, manufactured by Natco Pharma, which are bioequivalent to Lynparza.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Natco Pharma
Indian pharmaceutical company
- FDA
Related events
- Mylan is seeking regulatory approval from the FDA for new products and has listed its stock on the Nasdaq exchange.
- Decoy Therapeutics is listed on the Nasdaq stock exchange and is currently seeking expedited regulatory approval via FDA pathways.
- Amylyx Pharmaceuticals is seeking FDA approval for a new drug treatment.